Profil
Ning Zhao was the founder of Wuxi PharmaTech (Cayman), Inc. (founded in 2000) and WuXi AppTec Co., Ltd.
(founded in 2000), where she held the titles of Director (2000-2012) and Director, SVP-Operations & Head Human Resources (2009-2016), respectively.
She also held former positions as Head-Discovery Analytical Sciences at Bristol Myers Squibb Co. and Senior Research Scientist at Wyeth Pharmaceuticals LLC.
Dr. Zhao's education includes a doctorate degree from The Trustees of Columbia University in The City of New York (1995), another doctorate degree from the same institution, and an undergraduate degree from Peking University.
Anciens postes connus de Ning Zhao
Sociétés | Poste | Fin |
---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Founder | 16/05/2023 |
WUXI APPTEC CO., LTD. | Founder | 16/05/2023 |
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 16/05/2023 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Chief Tech/Sci/R&D Officer | 04/04/2012 |
Formation de Ning Zhao
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |